NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
18 hedge funds and large institutions have $21.6M invested in Nexvet Biopharma plc Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
2
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$410K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$424 |
Top Sellers
| 1 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$20.4K |
| 2 |
CI
Cowen Inc
New York
|
-$11.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.09K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.06K |
| 5 |
Citigroup
New York
|
-$1.83K |
